Jonathan P. Mow
2019
In 2019, Jonathan P. Mow earned a total compensation of $1.2M as Chief Executive Officer at PhaseBio Pharmaceuticals, a 102% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $232,500 |
|---|---|
| Option Awards | $524,291 |
| Salary | $436,183 |
| Other | $10,099 |
| Total | $1,203,072 |
Mow received $524.3K in option awards, accounting for 44% of the total pay in 2019.
Mow also received $232.5K in non-equity incentive plan, $436.2K in salary and $10.1K in other compensation.
Rankings
In 2019, Jonathan P. Mow's compensation ranked 8,422nd out of 13,971 executives tracked by ExecPay. In other words, Mow earned more than 39.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,422 out of 13,971 | 40th |
Division Manufacturing | 3,331 out of 5,695 | 42nd |
Major group Chemicals And Allied Products | 1,258 out of 2,194 | 43rd |
Industry group Drugs | 1,068 out of 1,880 | 43rd |
Industry Pharmaceutical Preparations | 793 out of 1,392 | 43rd |
Source: SEC filing on April 24, 2020.
Mow's colleagues
We found two more compensation records of executives who worked with Jonathan P. Mow at PhaseBio Pharmaceuticals in 2019.